HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hongtao Liu Selected Research

Myelodysplastic Syndromes (Myelodysplastic Syndrome)

12/2021A 2:1 randomized, open-label, phase II study of selinexor vs. physician's choice in older patients with relapsed or refractory acute myeloid leukemia.
11/2020Phase I trial of maintenance selinexor after allogeneic hematopoietic stem cell transplantation for patients with acute myeloid leukemia and myelodysplastic syndrome.
1/2020A phase 1 study of azacitidine with high-dose cytarabine and mitoxantrone in high-risk acute myeloid leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hongtao Liu Research Topics

Disease

50Neoplasms (Cancer)
12/2021 - 08/2009
21Esophageal Squamous Cell Carcinoma
11/2021 - 03/2010
20Inflammation (Inflammations)
01/2022 - 01/2003
12Infections
04/2022 - 01/2014
12Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 03/2013
9Hypoxia (Hypoxemia)
12/2021 - 01/2012
7Insulin Resistance
01/2022 - 01/2011
7Carcinogenesis
12/2021 - 02/2015
6Necrosis
01/2022 - 03/2006
6Dysbiosis
01/2022 - 06/2018
6Neoplasm Metastasis (Metastasis)
12/2021 - 04/2014
5Hematologic Neoplasms (Hematological Malignancy)
07/2021 - 01/2019
5Meningitis
03/2021 - 04/2016
5Leukemia
01/2021 - 05/2013
5Brain Injuries (Brain Injury)
01/2020 - 11/2018
5Breast Neoplasms (Breast Cancer)
01/2020 - 02/2011
4Fibrosis (Cirrhosis)
04/2022 - 11/2018
4Type 2 Diabetes Mellitus (MODY)
01/2022 - 06/2018
4Lymphatic Metastasis
11/2021 - 01/2014
4Wounds and Injuries (Trauma)
08/2021 - 01/2019
4Body Weight (Weight, Body)
06/2021 - 11/2015
4Obesity
03/2021 - 11/2018
4Aortic Dissection
01/2020 - 02/2019
4Rheumatoid Arthritis
12/2004 - 01/2003
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2022 - 01/2020
3Dyslipidemias (Dyslipidemia)
06/2022 - 04/2017
3Non-alcoholic Fatty Liver Disease
04/2022 - 01/2019
3Constipation
03/2022 - 02/2021
3Glucose Intolerance
01/2022 - 01/2019
3Cognitive Dysfunction
12/2021 - 12/2018
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
12/2021 - 01/2020
3Esophageal Neoplasms (Esophageal Cancer)
09/2021 - 05/2017
3Lung Neoplasms (Lung Cancer)
08/2021 - 08/2018
3Vomiting
01/2021 - 01/2018
3Ischemia
07/2020 - 01/2019
3Pathologic Complete Response
01/2020 - 01/2018
3Graft vs Host Disease (Graft-Versus-Host Disease)
01/2020 - 05/2013
3Pancreatic Neoplasms (Pancreatic Cancer)
04/2019 - 11/2017
3Carcinoma (Carcinomatosis)
02/2015 - 10/2009
2Lipid Metabolism Disorders (Metabolism Disorders, Lipid)
06/2022 - 01/2021
2Pain (Aches)
04/2022 - 01/2020
2Heart Failure
02/2022 - 01/2020
2Tetralogy of Fallot (Fallot Tetralogy)
02/2022 - 10/2021
2Neuroinflammatory Diseases
01/2022 - 01/2020

Drug/Important Bio-Agent (IBA)

25Proteins (Proteins, Gene)FDA Link
12/2021 - 12/2005
12Biomarkers (Surrogate Marker)IBA
01/2022 - 02/2015
11OligosaccharidesIBA
04/2022 - 04/2017
10Glucose (Dextrose)FDA LinkGeneric
01/2022 - 06/2018
9Messenger RNA (mRNA)IBA
01/2022 - 12/2005
9Long Noncoding RNAIBA
12/2021 - 12/2019
9MicroRNAs (MicroRNA)IBA
04/2020 - 01/2012
7Biological ProductsIBA
12/2021 - 01/2014
6ChitosanIBA
03/2022 - 06/2018
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2022 - 11/2003
5DexmedetomidineFDA Link
04/2022 - 09/2019
5CytokinesIBA
12/2021 - 01/2003
5Small Interfering RNA (siRNA)IBA
03/2016 - 10/2010
4Interleukin-6 (Interleukin 6)IBA
11/2022 - 03/2018
4Bile Acids and Salts (Bile Acids)IBA
06/2022 - 01/2020
4LipidsIBA
06/2022 - 04/2017
4Blood Glucose (Blood Sugar)IBA
01/2022 - 03/2018
4selinexorIBA
12/2021 - 01/2018
4Cisplatin (Platino)FDA LinkGeneric
08/2021 - 08/2018
4EnzymesIBA
01/2021 - 01/2011
4CateninsIBA
09/2020 - 11/2010
3LipopolysaccharidesIBA
11/2022 - 01/2015
3NF-kappa B (NF-kB)IBA
11/2022 - 12/2004
3Loperamide (Imodium)FDA LinkGeneric
03/2022 - 02/2021
3NeuroglobinIBA
01/2022 - 08/2019
3RNA (Ribonucleic Acid)IBA
11/2021 - 01/2014
3AntigensIBA
07/2021 - 05/2013
3Pharmaceutical PreparationsIBA
01/2021 - 01/2019
3Anti-Bacterial Agents (Antibiotics)IBA
01/2021 - 01/2018
3Nicotinamide N-MethyltransferaseIBA
09/2020 - 10/2019
3Oxygen (Dioxygen)IBA
08/2019 - 01/2015
3Cyclin D1IBA
01/2016 - 10/2009
3Caspase 3 (Caspase-3)IBA
01/2016 - 10/2009
2Interleukin-1beta (Interleukin 1 beta)IBA
11/2022 - 04/2004
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2022 - 10/2021
2TNF Receptor-Associated Factor 6 (TRAF6)IBA
11/2022 - 08/2021
2LigandsIBA
11/2022 - 11/2003
2Glutathione (Reduced Glutathione)IBA
06/2022 - 11/2018
2Tryptophan (L-Tryptophan)FDA Link
06/2022 - 01/2020
2Fatty Acids (Saturated Fatty Acids)IBA
04/2022 - 04/2017
2Antiviral Agents (Antivirals)IBA
04/2022 - 10/2020
2TeaIBA
01/2022 - 03/2021
2Insulin (Novolin)FDA Link
01/2022 - 01/2022
2InterleukinsIBA
01/2022 - 07/2014
2Hemin (Panhematin)FDA Link
01/2022 - 01/2019
2Sevoflurane (Ultane)FDA LinkGeneric
01/2022 - 01/2019
2PPAR gammaIBA
01/2022 - 11/2018

Therapy/Procedure

20Therapeutics
07/2021 - 04/2004
12Drug Therapy (Chemotherapy)
08/2021 - 02/2015
7Cell Transplantation
11/2022 - 01/2019
6Transplantation
10/2021 - 01/2003
5Immunotherapy
07/2021 - 11/2017
5Stem Cell Transplantation
01/2020 - 04/2012
4Hematopoietic Stem Cell Transplantation
01/2021 - 03/2013
4Ligation
07/2020 - 04/2004
2Cardiopulmonary Bypass (Heart-Lung Bypass)
02/2022 - 10/2021